ABC | Volume 115, Nº2, Agosto 2020

Artigo Original Cadore et al. Angioplastia Preventiva no Infarto do Miocárdio Arq Bras Cardiol. 2020; 115(2):229-237 Potencial Conflito de Interesses Os autores declaram não haver conflito de interesses pertinentes. Fontes de Financiamento Opresente estudo não contou com fontes de financiamento externas. Vinculação Acadêmica Este artigo é parte de dissertação de Mestrado de Julia Cremona Cadore pela Universidade Federal do Rio Grande do Sul. 1. Sekercioglu N, Spencer FA, Lopes LC, Guyatt GH. Culprit vessel only vs immediate complete revascularization in patients with acute ST-Segment elevation myocardial infarction: systematic review and meta-analysis. Clin Cardiol. 2014;37(12):765-72. 2. Zhang D, Song X, Lv S, Yuan F, Xu F, ZhangM, et al. Culprit vessel only versus multivessel percutaneous coronary intervention in patients presenting with ST-segment elevation myocardial infarction and multivessel disease. PLoS One. 2014;9(3):e92316. 3. Park DW, Clare RM, Schulte PJ, Pieper KS, Shaw LK, Califf RM, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312(19):2019-27. 4. Levine GM, Bates ER, Balnkeship JC, Bailey SR, Bitti JA, Cercek J, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133:1135-47. 5. Wolny R, Pregowski J, Bekta P, Chmielak Z, Witkowski A. Early occlusion of the non-infarct-related coronary artery following successful primary percutaneous coronary intervention in ST-elevation myocardial infarction. Postepy Kardiol Interwencyjnej. 2015;11(2):136-40. 6. Levine GM, Bates ER, Blankenship JC, Bailey SR, Bitti JA, Cercek J, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574–651. 7. Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, et al. Randomized trial of preventive angioplasty inmyocardial infarction. N Engl J Med. 2013;369(12):1115-23. 8. Kelly DJ, Mc Cann GP, Blackman D, Curzen NP, Dalby M, Grennwood JP, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015;65(10):963-72. 9. Hlinomaz O. Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy. PRAGUE 13 trial. [citado 10 Set. 2015]. Disponível em: http://sbhci.org.br/ wp-content/uploads/2015/05/PRAGUE-13-Trial.pdf. 10. EngstrømT, Kelbæk H, Helqvist S, Hofsten DE, Klovgaard L, Holmvang L, et al. Complete revascularization versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI 3-PRIMULTI): an open-label, randomized controlled trial. Lancet. 2015;386(9994):665-71. 11. Ibanes B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESCGuidelines for themanagement of acutemyocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST- segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. 12. Piegas LS, Timerman A, Feitosa GS, Nicolau JC, Mattos LAP, Andrade MD, et al. VDiretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto Agudo do Miocárdio com Supradesnível do Segmento ST. Arq Bras Cardiol. 2015;105(2 Suppl 1):1-105. 13. Pollack A, Mohanty BD, Handa R, Looser PM, Fuster V, King III Sb, et al. Preventive stenting in acute myocardial infarction. JACC Cardiovasc Interv. 2015;8(1 PtB):131-8. 14. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O´Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343(13):915-22. 15. Lekston A, TajstraM, Gasior M, GierlotkaM, Pres D, Hudzik B, et al. Impact of multivessel coronary disease on one-year clinical outcomes and five-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. Kardio Pol. 2011;69(4):336-43. 16. Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry). Am J Cardiol. 2010;106(3):342-7. 17. Bengalore S, Kumar S, Poddar KL, Ramasamy S, Rha SW, Faxon DP. Meta- analysis of multivessel coronary artery revascularization versus culprit only revascularization inpatientswithST-segmentelevationmyocardial infarction and multivessel disease. Am J Cardiol. 2011;107(9):1300-10. 18. Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen BE, et al. Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS- AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol. 2011;58(7):704-11. 19. Santos AR, Piçarra BC, Celeiro M, Bento A, Aguiar J. Multivessel approach in ST-elevation myocardial infarction: impact on in-hospital morbidity and mortality. Rev Port Cardiol. 2014;33(2):67-73. 20. De Luca G, Navarese E, Marino P. Risk profile and benefits fromGp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treatedwith primary angioplasty: ameta-regression analysis of randomized trials. Eur Heart J. 2009;30(22):2705-13. 21. Califf RM, Pryor DB, Greenfield JC. Beyond randomized trials: applying clinical experience in the treatment of patients with coronary artery disease. Circulation. 1986;74(6):1191-94. 22. JensenLO,ThayssenP,FarkasDK,HougaardM,TekelsenCJ,TilstedHH,etal. Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease. EuroIntervention. 2012;8(4):456-64. Referências 236